Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: Results of the platelet aggregation receptor antagonist dose investigation and reperfusion gain in myocardial infarction (PARADIGM) trial

R. A. Harrington, F. Van de Werf, A. Luyten, B. Potkin, N. McIntosh-Yellin, C. Morgan, K. Feskiw, K. Finnie, S. McCreery, J. Diodati, E. Shalit, S. Roth, J. Smith, W. Hui, L. Kvill, M. Senaratne, M. Goeres, P. Greenwood, A. Prosser, A. KristinssonV. Runarsdottir, G. Oddsson, H. Plardardottir, A. B. Chandler, M. Edwards, J. Becker, S. Nallcy, R. Becker, S. Ball, E. Bates, T. Johnson, R. Harrington, K. Quintero, A. Paraschos, L. Paraschos, K. Lerrick, B. Spinogatti, N. Bhalodkar, A. Valeria, D. Moliterno, P. Desantis, J. K. White, K. Andreatta, J. Burks, N. Kohler, J. Seaworth, J. Jensen, G. Carreon, T. Nygaard, J. White, J. Puma, L. Jones, P. Armstrong, W. Sutherland, E. Topol, D. Moliterno, R. Califf, R. Harrington, K. Newby, M. Peek, C. Binanay, K. Tinnin, M. Bhapkar, M. Dorsey, J. Parker, B. Tardiff, J. Alexander, B. Crenshaw, C. Green, G. Strand, M. Krucoff, K. Trollinger, C. Green, S. Ellis, T. Ivanc, D. Debowey, W. Hillegass, M. Lincoff, J. Tcheng, A. Rames, B. Steiner, M. Bokslag, D. Marcantuono, E. Luiden, T. Nielsen

Research output: Contribution to journalArticlepeer-review

133 Scopus citations

Fingerprint

Dive into the research topics of 'Combining thrombolysis with the platelet glycoprotein IIb/IIIa inhibitor lamifiban: Results of the platelet aggregation receptor antagonist dose investigation and reperfusion gain in myocardial infarction (PARADIGM) trial'. Together they form a unique fingerprint.

Medicine & Life Sciences